Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Pusch

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Infectious Diseases|March 4, 2014
Therapy duration and long-term outcomes in extra-pulmonary tuberculosisTobias Pusch, Jotam G Pasipanodya, Ronald G Hall, et al.
American Journal of Infection Control|June 26, 2012
Controlling outbreak of vancomycin-resistant Enterococcus faecium among infants caused by an endemic strain in adult inpatientsTobias Pusch, Dale Kemp, Sylvia Trevino, et al.
Nature|April 5, 2019
Ultrafast spin-lasersMarkus Lindemann, Gaofeng Xu, Tobias Pusch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2015
Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activityMartin Vaeth, Carina A Bäuerlein, Tobias Pusch, et al.
Translational Vision Science & Technology|July 31, 2024
Utility of a Model to Predict Endothelial Cell Density of Donor Corneas to Determine Suitability for TransplantationJulia B Bu, Stephanie D Grabitz, Franziska Schön, et al.
Optics Letters|May 15, 2026
Phase-engineered distributed grating reliefs for high-power single-mode 795-nm VCSELs with on-axis emissionJulian Lindner, Stephan Gronenborn, Valerio Torrelli, et al.
Frontiers in Immunology|June 28, 2018
The Transcription Factor NFATc1 Supports the Rejection of Heterotopic Heart AllograftsJohannes Baur, Christoph Otto, Ulrich Steger, et al.
Open Forum Infectious Diseases|August 3, 2022
Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram-Negative Bacteremia: A Prospective Randomized TrialAlyssa B Christensen, Brent Footer, Tobias Pusch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2013
NFATc1 induction in peripheral T and B lymphocytesMatthias Hock, Martin Vaeth, Ronald Rudolf, et al.
Nature Communications|September 13, 2017
NFATc1 controls the cytotoxicity of CD8<sup>+</sup> T cellsStefan Klein-Hessling, Khalid Muhammad, Matthias Klein, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Infectious Diseases|March 4, 2014
Therapy duration and long-term outcomes in extra-pulmonary tuberculosisTobias Pusch, Jotam G Pasipanodya, Ronald G Hall, et al.
American Journal of Infection Control|June 26, 2012
Controlling outbreak of vancomycin-resistant Enterococcus faecium among infants caused by an endemic strain in adult inpatientsTobias Pusch, Dale Kemp, Sylvia Trevino, et al.
Nature|April 5, 2019
Ultrafast spin-lasersMarkus Lindemann, Gaofeng Xu, Tobias Pusch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2015
Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activityMartin Vaeth, Carina A Bäuerlein, Tobias Pusch, et al.
Translational Vision Science & Technology|July 31, 2024
Utility of a Model to Predict Endothelial Cell Density of Donor Corneas to Determine Suitability for TransplantationJulia B Bu, Stephanie D Grabitz, Franziska Schön, et al.
Optics Letters|May 15, 2026
Phase-engineered distributed grating reliefs for high-power single-mode 795-nm VCSELs with on-axis emissionJulian Lindner, Stephan Gronenborn, Valerio Torrelli, et al.
Frontiers in Immunology|June 28, 2018
The Transcription Factor NFATc1 Supports the Rejection of Heterotopic Heart AllograftsJohannes Baur, Christoph Otto, Ulrich Steger, et al.
Open Forum Infectious Diseases|August 3, 2022
Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram-Negative Bacteremia: A Prospective Randomized TrialAlyssa B Christensen, Brent Footer, Tobias Pusch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2013
NFATc1 induction in peripheral T and B lymphocytesMatthias Hock, Martin Vaeth, Ronald Rudolf, et al.
Nature Communications|September 13, 2017
NFATc1 controls the cytotoxicity of CD8<sup>+</sup> T cellsStefan Klein-Hessling, Khalid Muhammad, Matthias Klein, et al.
Pageof 2